This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

S&P Replaces Covidien With MetLife In S&P 100

NEW YORK (AP) ¿ Standard & Poor's said Thursday it has added insurer MetLife Inc. to the S&P 100, replacing health care products company Covidien Ltd., which will be ineligible for the index after it redomesticates to Ireland.

In addition, Houston-based FMC Technologies Inc., which provides technology services to the energy industry, will replace Covidien in the S&P 500 index. Shares of companies added to the S&P 500 often rise, since many investment portfolios are linked to the index.

At the same time, Columbia, Md.-based software provider Micros Systems Inc. will replace FMC in the S&P MidCap 400 and North Hollywood, Calif.-based physician group IPC The Hospitalist Company Inc. will replace Micros in the S&P SmallCap 600.

Separately, Simmons First National Corp., which owns community banks in Arkansas, will replace Guaranty Financial Group Inc. in the S&P SmallCap 600. DTS Inc., which makes parts for entertainment systems, will also replace Irwin Financial Corp. in that index.

As of Thursday's close, Guaranty Financial and Irwin Financial had market capitalizations of about $37 million and $35 million respectively, well below the index's minimum market cap of $200 million.

Standard & Poor's is a subsidiary of McGraw-Hill Cos.
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
IPCM $80.17 0.01%
COV $106.71 -1.26%
DTSI $20.42 -0.39%
FTI $28.64 0.25%
MET $43.03 0.51%


Chart of I:DJI
DOW 17,740.63 +79.92 0.45%
S&P 500 2,057.14 +6.51 0.32%
NASDAQ 4,736.1550 +19.0610 0.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs